Bioinformatics combined with clinical data to analyze clinical characteristics and prognosis in patients with HER2 low expression breast cancer.

Yongcheng Chen,Yanfei Ma,Yanghong Li, Yanrong Yu, Bimin Lu, Liangyan Liao, Fujun Li, Zipeng Wen, Wenjun Jiang, Pengwei Guo,Dalang Fang,Guanming Lu

Gland surgery（2023）

引用 0|浏览2

暂无评分

摘要

Compared with HER2 zero expression, HER2 low patients express more ER and PR, and have less short-term recurrence and metastasis, but there is no obvious difference in DFS between the two groups.

查看译文

关键词

Breast cancer (BC),clinicopathologic features,human epidermal growth factor receptor 2 (HER2),prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要